Phenominer Database Results (16 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Record ID Study ID
SD ejection fraction artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 72.0 days 5 76.0 % 5.0 11.18 echocardiography 0.0 ACF 2 days 99372 2278
SD ejection fraction artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male  days 6 75.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98882 2160
SD ejection fraction sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male  days 6 63.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 sham ACF 720 min 98881 2160
SD ejection fraction artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 72.0 days 5 79.0 % 3.0 6.71 echocardiography 0.0 ACF 2 days 99374 2278
SD ejection fraction artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male  days 6 65.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98878 2160
SD ejection fraction sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male  days 6 65.0 % 2.0 4.9 HP Sonos 5500 echo ultrasound 1.0 sham ACF 360 min 98879 2160
SD ejection fraction sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male  days 6 65.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 sham ACF 2 days 98883 2160
SD ejection fraction sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male  days 6 64.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 sham ACF 5 days 98885 2160
SD ejection fraction artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 98.0 days 8 63.0 % 2.0 5.66 echocardiography 0.0 ACF 28 days 99376 2278
SD ejection fraction sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 98.0 days 7 66.0 % 2.0 5.29 echocardiography 0.0 sham ACF 28 days 99375 2278
SD ejection fraction artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 98.0 days 8 71.0 % 1.0 2.83 echocardiography 0.0 ACF 28 days 99378 2278
SD ejection fraction artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male  days 6 66.0 % 4.0 9.8 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98880 2160
SD ejection fraction artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male  days 6 75.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98884 2160
SD ejection fraction sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 72.0 days 5 66.0 % 3.0 6.71 echocardiography 0.0 sham ACF 2 days 99371 2278
SD ejection fraction sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 72.0 days 5 72.0 % 2.0 4.47 echocardiography 0.0 sham ACF 2 days 99373 2278
SD ejection fraction sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 98.0 days 7 67.0 % 2.0 5.29 echocardiography 0.0 sham ACF 28 days 99377 2278